RFK Jr. is quietly reshaping vaccine policy. This is the man helping him do it.
The 60-year-old conservative with a stout build and a boyish haircut was mostly unknown to the doctors, epidemiologists and officials who had gathered to ask questions about what many have described as the gutting of their agency and the threat many believe its new leaders pose to public health.
When asked about the researchers and doctors reportedly aligned with the anti-vaccine movement who had replaced the qualified experts on the Advisory Committee on Immunization Practices (ACIP), a federal vaccine advisory committee, deputy director of public affairs Nina Witkofsky opened the floor to Burns, who was seated at a long table with other agency leaders.
'I'll catch the football on that one,' said Burns, who had been recently appointed as senior adviser to the CDC director (a position that is still sitting vacant). 'We've been working really hard over the past few days — over the weekend in particular — to bring on the new ACIP members,' he said with a smile.
Burns said he had been on calls with agency staff, working nights and weekends ahead of the July ACIP meeting, to ensure the replacements were in place — new panelists who, critics later said, would bring anti-vaccine views and conflicts of interest to a group once respected for its scientific rigor and independence. 'We're making good progress,' Burns said, according to a recording of the meeting obtained by MSNBC. He added that several agenda items would be delayed while the new panel got up to speed.
Though not everyone in the room recognized him, Burns had been named in an April memo from Matt Buzzelli, the CDC's newly politically appointed chief of staff, announcing interim leadership changes after mass terminations and resignations. But among the CDC's longest-serving employees, especially those in offices related to vaccines, Burns was a known entity. He had been a staffer for congressional Republicans since the early '90s — best known as a key operator for the anti-vaccine movement.
Originally from Georgia, Burns spent the last three decades in Florida, Texas and Washington, D.C., with his longest tenure, from 1995 to 2008, as legislative director and deputy chief of staff to former Rep. Dave Weldon, R-Fla. Health and Human Services Secretary Robert F. Kennedy Jr. had wanted Weldon as CDC director, but that nomination was pulled over his anti-vaccine views. But because an adviser position doesn't require Senate confirmation, Kennedy got Weldon's number two.
Burns is not a doctor or a scientist. An HHS spokesperson declined to be quoted on the record but defended Burns' management of vaccine projects for the agency. The spokesperson said that Burns had worked on health policy as a legislative aide for congressional Republicans. Burns did not respond to MSNBC's requests for comment.
Weldon's office was central to the early-2000s push to link vaccines to autism, and Burns was a key operator within the effort, acting as a liaison among activists and researchers. His work as deputy chief of staff in the early 2000s, chronicled in books and news reports from the time, was also described to MSNBC by long-serving CDC employees and three former legislative staffers who served alongside Burns. He was interviewed several times for a sympathetic history of the period's anti-vaccine activism, 'Evidence of Harm.' Burns facilitated dozens of meetings between anti-vaccine activists and government officials, and arranged access to CDC data for Mark and David Geier, father-son researchers who falsely linked autism to vaccines and served as experts in legal cases alleging vaccine injuries. He coordinated press and lobbying strategies with activists, pushed medical journals to publish anti-vaccine research that had been rejected, and asked anti-vaccine activists to advise on government-funded research. He also publicly discounted studies that debunked purported links between vaccines and autism, and was repeatedly described in books, news articles and autism forums as a tireless behind-the-scenes organizer.
One source with knowledge of calls between Weldon's office, CDC staffers and anti-vaccine researchers described Burns as 'explosive.' Burns, they said, organized meetings, brought anti-vaccine researchers like the Geiers onto calls without warning, and repeatedly demanded access to databases containing private patient information. They recalled Burns at times screaming and threatening agency funding, as Weldon sat on the House Appropriations Committee at the time.
It's not clear what has motivated his passion over vaccines, but one former CDC staffer who interacted with Burns all those years ago described it as something like a 'religious crusade.'
Burns is one of dozens of new political appointees across HHS agencies, some with minimal public health experience and others with clear ties to the anti-vaccine movement that Kennedy helped build.
In the last six months, Kennedy has dismantled and partly remade the country's largest federal agency, overseeing the firings of thousands of employees and shuttering programs related to issues including mental health, senior care, cancer, and HIV and AIDS. The CDC has been without a director since March, when Trump withdrew Kennedy's pick, Weldon, and nominated Susan Monarez. Leadership roles have been left vacant or filled with political appointees who lack public health experience. Kennedy has also placed anti-vaccine allies in roles that are reshaping vaccine policy — some subtly, others more overtly — both domestically and abroad. And it is Burns who appears to be leading this network of ideologically aligned staff embedded across HHS agencies.
According to meeting recordings, internal communications reviewed by MSNBC and three sources familiar with the situation, Burns has become a central figure in subverting vaccine policy under Kennedy. It's unclear from his job title of 'senior adviser' what Burns is officially tasked with, but officials with knowledge said Burns' duties were, in part, specifically targeting vaccines.
In addition to organizing the destruction and rebirth of the ACIP panel, Burns personally ordered the removal of a webpage that hosted a scientific review on the safety of thimerosal, an ingredient falsely linked to autism by anti-vaccine activists. (The ACIP panel ultimately recommended removing the preservative from influenza vaccines.) The decision to remove the report from the website, made after communication with Kennedy's office, broke from standard practice, which allows such panels to act independently of the agency. An HHS spokesperson defended the removal to MSNBC, saying the report had been posted without permission, but did not address Burns' involvement.
Kennedy's sweeping plans for vaccines include the re-examination of settled vaccine safety studies, particularly around autism. Kennedy has said that this fall he will announce preliminary findings from a reanalysis of health data — findings that critics, including those inside CDC, say are preordained and are likely to reignite disproven claims around autism and vaccines.
Kennedy's overhaul of vaccine policy is also coming amid a growing number of public health emergencies. Measles outbreaks tore through the country this year, hospitalizing hundreds and killing two unvaccinated children. The country's elimination status is under threat while vaccine hesitancy grows: a recent study found that only 40% of pregnant Americans and parents of young children said they plan to follow the recommended vaccine schedule.
Meanwhile, Burns appears to be benefitting from a power vacuum. Two Trump loyalists — Heather Flick Melanson, Kennedy's chief of staff, and Hannah Anderson, a senior policy adviser — were fired this week. Key positions, including CDC director and several division heads, remain unfilled. Nearly a third of top HHS leadership positions currently sit vacant, according to the agency's website. With few career leaders in place, political appointees have been operating with unusual authority. Burns has wielded his new power to realize an old dream.
'He's a senior adviser to the director, but there is no director,' said one official, who spoke on the condition of anonymity because they aren't authorized to speak publicly about the agency. 'And all that he does, all day long, is work in this covert vaccine space.'
Dr. Paul Offit, the inventor of a rotavirus vaccine and a longtime critic of Kennedy and the anti-vaccine movement, suggested that Kennedy's actions are like the dinosaur in 'Jurassic Park,' testing the fence before it breaks through.
'Activists have been shouting from the sidelines for decades,' Offit said. 'Now they are making policy.'
This article was originally published on MSNBC.com
Solve the daily Crossword

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Cutting-edge Diagnostic Technologies Transforming $6.4 Billion Landscape
The U.S. Alzheimer's disease diagnostics market, valued at USD 3.53 billion in 2024, is projected to grow at a CAGR of 10.6% from 2025-2030. Growth is driven by rising Alzheimer's prevalence and advanced diagnostics like FDA-approved blood tests, improving early detection and care planning. U.S. Alzheimer's Disease Diagnostics Market Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "U.S. Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), By Type, By End-use, And Segment Forecasts, 2025 - 2030" report has been added to U.S. Alzheimer's disease diagnostics market was valued at USD 3.53 billion in 2024 and is expected to grow at a CAGR of 10.6% from 2025 to 2030 This growth is driven by the rising prevalence of Alzheimer's disease and increasing emphasis on early and accurate diagnosis. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 6.7 million older adults in the U.S. were living with Alzheimer's disease in 2024, a number projected to nearly double by 2060. The growing prevalence of the disease prompted government and private healthcare bodies to invest heavily in advanced diagnostic technologies such as PET imaging, cerebrospinal fluid biomarkers, and blood-based diagnostics. The growth of the U.S. Alzheimer's disease diagnostics market is due to the recent regulatory approval of advanced, non-invasive diagnostic technologies. The U.S. FDA granted marketing clearance for the first in vitro diagnostic device that utilizes a blood test to support the diagnosis of Alzheimer's disease. The Lumipulse G pTau217/b-Amyloid 1-42 Plasma Ratio is specifically intended for the early detection of amyloid plaque accumulation, a hallmark of Alzheimer's pathology, in adult patients aged 55 years and older who are exhibiting clinical signs and symptoms consistent with cognitive development represents a major advancement in Alzheimer's diagnostics, significantly lowering access barriers by providing a cost-effective and minimally invasive alternative to PET scans and lumbar punctures, which often carry procedural risks. The FDA highlighted that this approval makes it easier and potentially more accessible for U.S. patients earlier in the disease. It underscores the test's value in facilitating timely intervention and clinical decision-making in the early stages of Alzheimer's disease increasing rate of dementia diagnosis among older adults is driving the growth of the U.S. Alzheimer's diagnostics market. According to the 2022 National Health Interview Survey by the CDC, approximately 4% of individuals aged 65 and older have been diagnosed with dementia, with this figure rising to 13% among those aged 85 and above. This growth is primarily attributed to longer life expectancy, enhanced awareness, and improved diagnostic practices across clinical settings. The rising need for scalable, accurate diagnostic solutions to support early detection, appropriate intervention, and optimized care planning. Why should you buy this report? Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments. Competitive Landscape: Explore the market presence of key players worldwide. Future Trends: Discover the pivotal trends and drivers shaping the future of the global market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report Attribute Details No. of Pages 80 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $3.53 Billion Forecasted Market Value (USD) by 2030 $6.43 Billion Compound Annual Growth Rate 10.6% Regions Covered United States Competitive Landscape GE HealthCare Siemens Healthineers AG Canon Medical Systems Corporation Cerveau Technologies, Inc. Neurovision Imaging, Inc. Thermo Fisher Scientific Inc. Bio-Rad Laboratories, Inc. Quanterix Corporation Alzheon Inc. NanoSomiX, Inc. DiamiR Biosciences Company Overview Financial Performance Diagnostic Technique Portfolio Recent Developments/ Strategic Initiatives U.S. Alzheimer's Disease Diagnostics Market Report SegmentationDiagnostic Technique Outlook (Revenue, USD Million, 2018 - 2030) Biomarkers CSF Biomarkers Blood-Based Biomarkers Imaging Diagnostic Techniques Genetic Testing Cognitive Assessment Tests Type Outlook (Revenue, USD Million, 2018 - 2030) Triage Diagnosis Screening End Use Outlook (Revenue, USD Million, 2018 - 2030) Hospitals Diagnostic Laboratories Academic & Research Institutes For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Alzheimer's Disease Diagnostics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio

CNN
15 minutes ago
- CNN
5 things to know for July 28: Gaza, Tariffs, Walmart attack, Missing mom and child, Pets
A federal judge has dismissed a Trump administration lawsuit against Chicago's 'sanctuary' laws. The suit claimed that these local statutes 'thwart' federal efforts to enforce immigration laws. However, Judge Lindsay Jenkins said the US lacked standing to sue. Similar suits have been filed against Los Angeles, New York City, Denver and four cities in New Jersey. Here's what else you need to know to get up to speed and on with your day. An internal US government review found no evidence of widespread theft by Hamas of US-funded humanitarian aid in Gaza. The analysis, conducted by the US Agency for International Development, contradicts the State Department's claims that were used to justify backing the Gaza Humanitarian Fund, a controversial organization that took over aid distribution in the enclave. According to the Palestinian Health Ministry and the UN, more than 1,000 people have been killed by Israeli forces as they sought aid, with 60% killed while trying to reach GHF sites. Thousands of Palestinians are suffering from malnutrition and more than a dozen people starved to death last week amid Israel's humanitarian blockade. Even doctors and nurses are collapsing from hunger and exhaustion as they try to administer help. The US and the European Union have managed to avoid an economically crippling trade war. President Donald Trump and European Commission President Ursula von der Leyen shook hands in Scotland on Sunday after agreeing on the framework for a trade deal between two of the world's biggest economies. The agreement sets a 15% tariff on most European goods entering the US, which is higher than the 10% tariff Trump put in place on April 2 and significantly higher than the average of around 1.2% from before Trump's presidency. Yet it's lower than the 50% tariff Trump threatened in May when trade talks were stymied. Trump backed off that threat after speaking with von der Leyen, who called him to say the EU would commit to moving 'swiftly and decisively.' Police in Grand Traverse, Michigan, are praising bystanders who cornered the suspect in a violent stabbing attack. Bradford James Gille, 42, entered a Walmart on Saturday afternoon, waited inside for 35 minutes, then allegedly began stabbing random strangers with a foldable knife, authorities said. As the suspect fled into the parking lot, several bystanders gave chase, including an unarmed former Marine named Matt Kolakowski and his brother-in-law, Chris O'Brien. After another bystander, also a former Marine, pulled out his gun, the suspect dropped the knife. That's when Kolakowski subdued the attacker and held him until police arrived. 'I just turned into somebody that I haven't been in a long time and just stayed on top of him until the deputy ran up and jumped on top of him with a rifle in his face, and I helped the deputy arrest him,' Kolakowski said. All 11 victims – who are between the ages of 29 and 84 – are expected to survive. A California mother and her 8-month-old daughter are missing and haven't been seen for nearly two weeks. Family, friends and authorities are asking for the public's help in finding Whisper Owen, 36, and her infant daughter Sandra McCarty. Owen, who is also the mother of three other children, is described as 5'6', 145 lbs., with blue eyes and brown hair. Sandra is 1'10', 17 lbs., with green eyes and brown hair. On July 15, the pair left Fresno to return to their home near Sacramento. A traffic camera last captured their vehicle — a silver 2006 Chevrolet Trailblazer, license plate number 9LKH008, with damage to its driver's side headlight — shortly after 8 p.m. that night in Atwater. 'I'm desperate to find my daughter and her baby,' Owen's mother, Vickie Torres, told CNN. 'It's like she vanished into thin air.' Animal rescues and shelters across the US are reporting sharp increases in surrendered pets. Several of those organizations have told CNN that financial hardship is at the root of those owners' decisions. The cost of owning a pet — food, toys, grooming, vet visits, etc. — has increased in recent years. Some tariff-sensitive goods are expected to be even pricier in the months to come. Many pet owners are also facing a deterioration in financial stability, including the rising cost of living, debt burdens, an unexpected (human or animal) medical event or a job loss. 'It just breaks us to see people cry that they have to give up their animal because they have to move somewhere that's more affordable, and that place that's more affordable for them doesn't allow animals,' said Megan Larson, intake manager at Ruff Start Rescue in Minnesota. 'This is a very devastating decision that these people are forced to make. People don't want to do this.' GET '5 THINGS' IN YOUR INBOX If your day doesn't start until you're up to speed on the latest headlines, then let us introduce you to your new favorite morning fix. Sign up here for the '5 Things' newsletter. A new tax law limits how much itemizers may deduct and expands the amount non-itemizers may claim. The building-sized object initially appeared to be on a potential collision course with Earth. Now it may have a new target. 'The Fantastic Four: First Steps' defeated a DC superhero to finish No. 1 at the box office over the weekend. The lucky fans who attended her farewell show in Las Vegas on Saturday night were treated to a starry lineup of surprise guests. The actress appeared in a new ad for the tech firm whose ex-CEO and HR chief were caught embracing on the 'kiss cam' at a Coldplay concert. Tom Lehrer, song satirist and mathematician, dies at 97Lehrer lampooned marriage, politics, racism and the Cold War in song, and was even nominated for a Grammy Award for best comedy performance (musical). However, he later abandoned his music career to teach math at Harvard and other universities. 15,000That's how many animals have been killed by a toxic algal bloom on South Australia's coastline. Fueled by a marine heat wave, the bloom has turned once-colorful ecosystems filled with thriving marine life into underwater graveyards. 'This is not about politics or borders or anything like that. It's about people helping people, and it's a community helping another community.' — Mexican firefighter Jorge Fuentes Fuentes is a member of the rescue group Fundación 911, which was one of the earliest first responders to the devastating flash floods in central Texas earlier this month. 🌤️ Check your local forecast to see what you can expect. That's why NASA and its international partners are developing a new way to measure time in space. Today's edition of 5 Things AM was edited and produced by CNN's Andrew Torgan.


Fox News
15 minutes ago
- Fox News
Stephen A Smith calls out 'leaderless' Democrats amid party's record-low polling
Attorney Mehek Cooke on the Democratic Party's record-low polling, the work Republicans need to do to deliver promises to the American people and Jay Leno's criticism of late-night comedians for alienating half of their audience with politics.